Thomas Kamradt

12.4k citations

139 papers · 8.3k indexed · 3 hit papers · h-index 47

Impact in

Immunology top 0.2%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- IL-33, ST2, and ILC Pathways
- Immunotherapy and Immune Responses
- Psoriasis: Treatment and Pathogenesis
- Immune Response and Inflammation
Parasitology top 1%

Papers in

Immunology 101
- T-cell and B-cell Immunology 41
- Immune Cell Function and Interaction 34
- Immunotherapy and Immune Responses 23
- IL-33, ST2, and ILC Pathways 19
- Immune Response and Inflammation 13
- Immunodeficiency and Autoimmune Disorders 13
Parasitology 14
- Vector-borne infectious diseases 11

Co-authors: Carmen Infante‐Duarte N Mitchison Anthony J. Coyle Kerstin Bonhagen José-Carlos Gutierrez-Ramos Michael C. Byrne Heidi F. Horton Andreas Radbruch
Journals: The Journal of Immunology (20 papers)European Journal of Immunology (13 papers)Arthritis Research & Therapy (7 papers)PLoS ONE (6 papers)Frontiers in Immunology (4 papers)
Partner nations: Germany United States United Kingdom

In The Last Decade

Thomas Kamradt

136 papers receiving 8.1k citations

Hit Papers

align trajectories log scale

The development of inflammatory TH-17 cells requires interferon-regulatory factor 4 2007 · 540 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2007 Nature Immunology
2003 Nature Immunology
1998 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Thomas Kamradt

Since Specialization

Citations

This map shows the geographic impact of Thomas Kamradt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Kamradt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Kamradt more than expected).

Fields of papers citing papers by Thomas Kamradt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Kamradt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Kamradt. The network helps show where Thomas Kamradt may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas Kamradt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas Kamradt Line = papers co-authored together Thomas Kamradt links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Age- and sex-associated differences in immune cell populations iScience ·Reza Gheitasi, Sabine Baumgart, Daniela Roell, Norman Rose, Carsten Watzl, Diana Dudziak, Nico Andreas, Oliwia Makarewicz, Sebastian Drube, Clara Schnizer, Thomas Kamradt, Sebastian Weis, Mathias W. Pletz	2025	2
2	Persistent humoral and CD4+ TH cell immunity after mild SARS-COV-2 infection—The CoNAN long-term study Frontiers in Immunology ·Clara Schnizer, Nico Andreas, Wolfgang Vivas, Thomas Kamradt, Michael Baier, Michael Kiehntopf, Stefan Glöckner, André Scherag, Bettina Löffler, Steffi Kolanos, Joel Guerra, Mathias W. Pletz, Sebastian Weis	2023	4
3	Mediterranean diet component oleic acid increases protective lipid mediators and improves trabecular bone in a Porphyromonas gingivalis inoculation model Journal Of Clinical Periodontology ·Annika Döding, Mira Hüfner, Franziska Nachtsheim, Viktoria Iffarth, Anna Bölter, Asisa Bastian, Judit Symmank, Nico Andreas, Patrick Schädel, Maria Thürmer, Kathrin Becker, Michael Wolf, C. W. Jacobs, Thomas Kamradt, Andreas Koeberle, Oliver Werz, Bernd W. Sigusch, Ulrike Schulze‐Späte	2022	7
4	IL‐3 is essential for ICOS‐L stabilization on mast cells, and sustains the IL‐33‐induced RORγt⁺ T_reg generation via enhanced IL‐6 induction Immunology ·Sebastian Drube, Sylvia Müller, Franziska Weber, Philine Wegner, Romy Loschinski, Matthias Gaestel, Andreas Hutloff, Thomas Kamradt, Nico Andreas	2021	5
5	T Cell Response After SARS-CoV-2 Vaccination in Immunocompromised Patients with Inflammatory Bowel Disease Journal of Crohn s and Colitis ·Philipp A. Reuken, Nico Andreas, Philip Grunert, Stefan Glöckner, Thomas Kamradt, Andreas Stallmach	2021	33
6	What Are the Peripheral Blood Determinants for Increased Osteoclast Formation in the Various Inflammatory Diseases Associated With Bone Loss? Frontiers in Immunology ·Teun J. de Vries, Ismail el Bakkali, Thomas Kamradt, Georg Schett, Ineke D.C. Jansen, Patrizia D’Amelio	2019	48
7	The p38-MK2/3 Module Is Critical for IL-33–Induced Signaling and Cytokine Production in Dendritic Cells The Journal of Immunology ·Christiane Göpfert, Nico Andreas, Franziska Weber, Norman Häfner, T.V. Yakovleva, Matthias Gaestel, Thomas Kamradt, Sebastian Drube	2017	29
8	MK2/3 Are Pivotal for IL-33–Induced and Mast Cell–Dependent Leukocyte Recruitment and the Resulting Skin Inflammation The Journal of Immunology ·Sebastian Drube, Florian Kraft, Jan Dudeck, Anna-Lena Müller, Franziska Weber, Christiane Göpfert, Isabel Meininger, Mandy Beyer, Ingo M. Irmler, Norman Häfner, Dagmar Schütz, Ralf Stumm, T. V. Yakovleva, Matthias Gaestel, Anne Dudeck, Thomas Kamradt	2016	49
9	Glucocorticoid therapy of antigen-induced arthritis depends on the dimerized glucocorticoid receptor in T cells Proceedings of the National Academy of Sciences ·Ulrike Baschant, Lucien Frappart, Una Rauchhaus, Lisa Bruns, Holger M. Reichardt, Thomas Kamradt, Rolf Bräuer, Jan Tuckermann	2011	84
10	Das adaptive Immunsystem DMW - Deutsche Medizinische Wochenschrift ·Thomas Kamradt, K Ferrari-Kühne	2011	2
11	Regulatory T cells control the transition from acute into chronic inflammation in glucose-6-phosphate isomerase-induced arthritis Annals of the Rheumatic Diseases ·Oliver Frey, Alexandra Reichel, Kerstin Bonhagen, Lars Morawietz, Una Rauchhaus, Thomas Kamradt	2010	36
12	The development of inflammatory TH-17 cells requires interferon-regulatory factor 4 Nature Immunology ·Anne Brüstle, Sylvia Heink, Magdalena Huber, Christine Rosenplänter, Christine Stadelmann, Philipp Yu, Enrico Arpaia, Tak W. Mak, Thomas Kamradt, Michael Lohoff Hit paper breakdown →	2007	540
13	Expression of selectin ligands on murine effector and IL‐10‐producing CD4⁺ T cells from non‐infected and infected tissues European Journal of Immunology ·Ute Kretschmer, Kerstin Bonhagen, Gudrun F. Debes, Hans‐Willi Mittrücker, Klaus J. Erb, Oliver Liesenfeld, Dietmar M. Zaiss, Thomas Kamradt, Uta Syrbe, Alf Hamann	2004	30
14	Immunization with Glucose-6-Phosphate Isomerase Induces T Cell-Dependent Peripheral Polyarthritis in Genetically Unaltered Mice The Journal of Immunology ·David Schubert, Bert Maier, Lars Morawietz, Veit Krenn, Thomas Kamradt	2004	108
15	Organ-Specific CD4+ T Cell Response During Listeria monocytogenes Infection The Journal of Immunology ·Mischo Kursar, Kerstin Bonhagen, Anne Köhler, Thomas Kamradt, Stefan H. E. Kaufmann, Hans‐Willi Mittrücker	2002	65
16	Multiple cross-reactive self-ligands forBorrelia burgdorferi-specific HLA-DR4-restricted T cells European Journal of Immunology ·Bert Maier, Marc Molinger, Andrew P. Cope, Lars Fugger, Jens Schneider‐Mergener, Grete Sønderstrup, Thomas Kamradt, Achim Kramer	2000	45
17	Sacroiliitis - it's not all B 27 Zeitschrift für Rheumatologie ·Marina Backhaus, Thomas Kamradt, D Loreck	1999	3
18	Autoreactivity versus autoaggression: a different perspective on human autoantigens Current Opinion in Immunology ·Sarah Parry, Frances Hall, Jennifer Olson, Thomas Kamradt, Grete Sønderstrup	1998	19
19	Immunology of Reactive Arthritides Annual Review of Immunology ·Gerd R Burmester, Angelika Daser, Thomas Kamradt, Andreas Krause, N Mitchison, Joachim Sieper, Norbert A. Wolf	1995	90
20	Natural history of HIV-infection in hemophiliacs: Clinical, immunological, and virological findings Journal of Molecular Medicine ·Thomas Kamradt, D. Niese, K. E. Schneweis, H.‐H. Brackmann, Bernd S. Kamps, Billy W. Loo, U. Hammerstein	1989	8

About Thomas Kamradt

Thomas Kamradt is a scholar working on Immunology, Parasitology, Rheumatology, Infectious Diseases and Immunology and Allergy, having authored 139 papers that have together received 8.3k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (41 papers), Immune Cell Function and Interaction (34 papers), Immunotherapy and Immune Responses (23 papers), IL-33, ST2, and ILC Pathways (19 papers), Immune Response and Inflammation (13 papers), Immunodeficiency and Autoimmune Disorders (13 papers), Vector-borne infectious diseases (11 papers) and Asthma and respiratory diseases (10 papers). The work is most often cited by research in Immunology (5.3k citations), Parasitology (571 citations), Rheumatology (1.2k citations), Immunology and Allergy (312 citations) and Infectious Diseases (860 citations). Thomas Kamradt has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Carmen Infante‐Duarte, N Mitchison, Anthony J. Coyle, Kerstin Bonhagen, José-Carlos Gutierrez-Ramos, Michael C. Byrne, Heidi F. Horton, Andreas Radbruch, Hans‐Willi Mittrücker and Sylvia Heink. Their work appears in journals such as The Journal of Immunology, European Journal of Immunology, Arthritis Research & Therapy, PLoS ONE and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact